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Modeling-Assisted Design of Thermostable Benzaldehyde
Lyases from Rhodococcus erythropolis for Continuous
Production of α-Hydroxy Ketones
Martin Peng,[a] Dominik L. Siebert,[a] Martin K. M. Engqvist,[b] Christof M. Niemeyer,[a] and
Kersten S. Rabe*[a]
Enantiopure α-hydroxy ketones are important building blocks
of active pharmaceutical ingredients (APIs), which can be
produced by thiamine-diphosphate-dependent lyases, such as
benzaldehyde lyase. Here we report the discovery of a novel
thermostable benzaldehyde lyase from Rhodococcus erythropolis
R138 (ReBAL). While the overall sequence identity to the only
experimentally confirmed benzaldehyde lyase from Pseudomo-
nas fluorescens Biovar I (PfBAL) was only 65%, comparison of a
structural model of ReBAL with the crystal structure of PfBAL
revealed only four divergent amino acids in the substrate
binding cavity. Based on rational design, we generated two
ReBAL variants, which were characterized along with the wild-
type enzyme in terms of their substrate spectrum, thermo-
stability and biocatalytic performance in the presence of
different co-solvents. We found that the new enzyme variants
have a significantly higher thermostability (up to 22 °C increase
in T50) and a different co-solvent-dependent activity. Using the
most stable variant immobilized in packed-bed reactors via the
SpyCatcher/SpyTag system, (R)-benzoin was synthesized from
benzaldehyde over a period of seven days with a stable space-
time-yield of 9.3 mmol · L-1 · d  1. Our work expands the important
class of benzaldehyde lyases and therefore contributes to the
development of continuous biocatalytic processes for the
production of α-hydroxy ketones and APIs.
Introduction
The production of active pharmaceutical ingredients (APIs) and
natural compounds with multiple stereocenters is a highly
topical field in research and development. Chiral α-hydroxy
ketone moieties are key structural units of natural products and
APIs of industrial relevance as they can be readily converted, for
example, into diols, amino alcohols or esters.[1] The enantiose-
lective synthesis of α-hydroxy ketones can be realized enzymati-
cally by using oxidoreductases, like alcohol dehydrogenases[2]
or benzil reductase,[3] or else, via thiamine-diphosphate (ThDP)-
dependent lyases, such as pyruvate decarboxylase, benzoylfor-
mate decarboxylase or benzaldehyde lyase.[1]
Benzaldehyde lyases (BAL, EC 4.1.2.38) catalyze the stereo-
selective homo-coupling and cross-coupling of two aldehydes
via benzoin condensation (Scheme 1) by employment of ThDP
and Mg2+ as cofactors. The BAL from Pseudomonas
fluorescens[4,5] (PfBAL) is the only experimentally confirmed
representative in this enzyme class recorded in the BRENDA[6]
and TEED[7] database to date (for more detailed analysis of TEED
database see supporting information page 20). It has an broad
substrate spectrum[8,9] and can also catalyze C  N bond
formations,[10] cyclizations[11] and intramolecular Stetter
reactions.[12] Moreover, via rational engineering of its binding
site, PfBAL was successfully altered to perform benzoylformate
decarboxylase[13] or formolase reactions.[14] However, current
applications are limited by the relatively low stability of this
enzyme. For example, PfBAL loses 40% of its initial activity
within 27 h in phosphate reaction buffer at pH 8 and 25 °C.[15]
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Scheme 1. Benzaldehyde lyase (BAL)-catalyzed formation of (R)-benzoin
derivate (2) as homo-coupling product of aromatic aldehydes (1) and
formation of (R)-2-hydroxy-3,3-dimethoxy-1-arylpropan-1-one (4) as cross-
coupling product of aromatic aldehydes (1) and 2,2-dimethoxyacetaldehyde
(3) investigated in this work. Ar: aromatic residue. For distinctive structures
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This is especially critical for the realization of continuously
operated flow reactors. Hence, continuous flow reactors using
this enzyme based on retention by membranes,[16,17] entrapment
in polyvinyl alcohol[18] or adsorption to silica particles[19] showed
limited success and were technically laborious. Likewise, several
strategies for the direct, site-selective immobilization of PfBAL
on solid supports by employment of genetically-encoded tag
systems, like the hexahistine (His6)-tag,
[19,20] HaloTag[21] or
aggregation-inducing tags,[22] did not show the desired per-
formance and only the His6-tag variant could be used in a
fluidic setup.[19]
Results and Discussion
To overcome the above limitations and to identify BAL enzymes
of higher stability that promise improved production of α-
hydroxy ketones in a continuous reaction, we used the
computational prediction tool Tome, which was recently
developed by combining datasets of amino acid composition of
individual enzymes with the optimal growth temperature of
organism in a machine learning model.[23] From the resulting set
of sequences, we selected three candidate enzymes. A potential
BAL from Rhodococcus erythropolis (ReBAL), which was selected
based on the highest sequence identity (see Table S1).
Although R. erythropolis is a mesophilic organism, individual
enzymes may exhibit much higher thermostability than the
growth temperature of the organism, as previously reported.[24]
Furthermore, one potential BAL each was selected from
Sphaerobacter thermophilus (StBAL) and Thermobacillus composti
(TcBAL). The enzymes were obtained by heterologous expres-
sion in Escherichia coli (Figure S1A, sequence data see Table S2)
and the raw cell lysates were initially screened for aromatic
ligase activity, using a literature-reported photometric assay[25]
based on the conversion of 2-furaldehyde (1a, Scheme 2) into
2,2’-furoin (2a) (see also Figure S1B).
The enzyme from R. erythropolis showed the desired activity
with 1a (Figure S1B), whereas the enzymes from S. thermophilus
and T. composti did not show any significant activity with this
substrate. This finding was reasonable since the selection of
these enzymes was based on sequence homology alone. In
order to better understand the results, we performed a multiple
sequence alignment of the three enzymes along with other
PfBAL-related enzymes described in the literature. The resulting
phylogenetic tree (Figure S2) revealed that the inactive StBAL
and TcBAL are indeed closer related to acetohydroxyacid
synthase (AHAS, E.C. 4.1.3.18) from Saccharomyces cerevisiae
then to PfBAL. This result suggested that the potential catalytic
activity of StBAL and TcBAL may include the decarboxylation of
pyruvate like AHAS,[26] rather than the desired benzoin con-
densation. In contrast and in line with the activity observed for
ReBAL, this enzyme is more closely related to PfBAL on the
sequence level. This finding also reflects the capability of both
organisms of origin to metabolize aromatic compounds. As
such, the organism of origin of PfBAL (P. fluoreszens Biovar I)
was specifically enriched in medium with anisoin as the sole
carbon and energy source,[4] and the gene encoding for ReBAL
is originally located on the plasmid pLRE138 from R. erythropolis
R138 that harbors several genes that were classified as involved
in uptake and metabolism of aromatic compounds.[27] The two
enzymes are of comparable length (ReBAL, 557 amino acids and
PfBAL, 562 amino acids) and share 283 identical and 83 similar
amino acids with only 9 gaps, indicating that 65% of the
sequence is conserved between the two variants (Figure S3).
Considering this high sequence similarity, we generated a 3D
model of the protein structure of ReBAL (Figure 1) based on the
crystal structure of PfBAL[28] using SWISS Model.[29–33] The model
suggests the same homotetrameric structure as found for the
PfBAL,[34] which can be described as a dimer of a dimers with
four active sites (Figure 1, orange circles) located at the inter-
face.
Comparison of the model of ReBAL (Figure 2A) with the
structure of PfBAL (Figure 2B) with respect to the residues
considered to mainly constitute the binding site[35] indicated
that these residues were highly conserved. The only exceptions
are Q112, E393, S416 and T479 in ReBAL, which are located in
Scheme 2. Distinctive aromatic aldehydes (1a–p) investigated in this work.
Figure 1. Proposed molecular structure of the benzaldehyde lyase ReBAL
from Rhodococcus erythropolis. The model is based on the crystal structure of
the tetrameric benzaldehyde lyase PfBAL from Pseudomonas fluorescens
(PDB: 3D7K),[28] with three twofold axes P, Q and R. The locations of the four
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an equivalent position as L112, Y397, G419 and F484 in PfBAL
as suggested from alignment data (Figure S3). These residues
lead to the formation of a larger and, at the same time, more
polar binding site in ReBAL, suggesting that the two enzymes
have different substrate scopes. However, no information on
the influence of the corresponding residues of PfBAL L112,
Y397, G419 on the catalytic properties of the enzyme are
available, except of position 484, where mutations have led to
an about 70% reduction of kcat for benzoin lysis.
[15]
We therefore decided to not only compare the activity and
selectivity of the wild-type ReBAL with the well characterized
PfBAL, but to also generate ReBAL variants with either a binding
site matched to PfBAL (matched, ReBALmat, Figure 2C) or an
even larger but less polar binding site (widened, ReBALwid,
Figure 2D). To this end, we used site-directed mutagenesis to
generate the ReBALmat variant bearing mutations Q112L, E393Y,
S416G and T479F as well as the ReBALwid variant with mutations
Q112A, E393A, S416G and T479A (for the corresponding primer
sequences see Table S3). The formation of larger binding sites
was also validated using CASTp[36] (Figure S5).
After heterologous expression, we purified ReBAL, ReBALmat
and ReBALwid as well as PfBAL in biological triplicates (Figure 3A)
and compared their thermostability. To this end, the temper-
ature-dependent loss of activity was characterized by incubat-
ing 5 μM enzyme in solutions containing 0.25 mM ThDP and
2.5 mM MgSO4 as cofactors for 10 min at defined temperatures
in the range of 30–80 °C. The above described 2-furaldehyde-
based activity assay was then used to determine the remaining
enzyme activity at 30 °C. T50 values, defined as the temperature
at which 50% of the initial enzyme activity still remained, were
determined from the plots of the residual activities against the
incubation temperatures (Figures S6–S9). The analysis (Fig-
ure 3B) showed a significantly increased T50 value for ReBAL
(59.7 °C�0.6) as compared to PfBAL (45.9 °C�0.4). Interestingly
the ReBALmat (66.0 °C�0.2) and the ReBALwid (68.4 °C�0.3)
variants showed an even higher T50 value. These findings could
be explained by the location of the binding site at the dimer
interface, where an exchange of amino acids might also affect
the interaction between both monomers resulting in an
increased overall stability as it has been previously reported for
other enzyme classes.[37]
In order to compare the activity of the here investigated
enzymes with published data, we directly determined the
turnover number (TON) for the conversion of benzaldehyde
(1b) into benzoin (2b, Scheme 1) for all four BAL variants using
an HPLC assay (Figure S10). For the PfBAL we obtained a TON of
234 s  1�11, which is comparable to previously reported
values.[21,38] For ReBAL we found an about 15 times lower
conversion of 1b of only 15 s  1�1. As expected, matching the
amino acids in the binding site of ReBAL to the residues found
in PfBAL led to a twofold increase of the TON to 36 s  1�1 for
the ReBALmat variant, while the larger binding site of ReBALwid
showed a slightly higher TON of 45 s  1�1. This finding can be
correlated with the replacement of polar residues in the binding
site with nonpolar residues, which should lead to an increased
affinity for the nonpolar (aromatic) substrate. This hypothesis is
in line with the activity of ReBALwid having the smallest number
of polar residues and showing the highest turnover of the
ReBAL variants. However, the significantly lower activity of the
ReBAL variants is compensated by their thermostability at
elevated temperature. For example, the residual activity of
ReBAL significantly exceeded that of PfBAL after incubation at
50 °C for 1 h (Figure S11).
Figure 2. Structure model of A) wild-type ReBAL and B) crystal structure of
PfBAL (PDB: 3D7K)[28] as well as models of C) ReBALmat and D) ReBALwid.
Models were generated using SWISS Model.[29–33] Stick models of all amino
acid residues of PfBAL, wild-type, matched and widened ReBAL within a
range of 6 Å of the catalytic site containing thiamine diphosphate (ThDP)
and benzoylphosphonic acid methyl ester (MBP) (gray). Amino acid residues,
which differ between PfBAL and ReBAL and were mutated in ReBALmat and
ReBALwid, are represented as orange sticks. Coordinates of the ThDP-MBP
adduct in the modeled structures were superimposed from the crystal
structure of PfBAL.[28] For a surface representation of the binding sites, see
Figure S4.
Figure 3. A) His6-tagged PfBAL (60 kDa, 1), ReBAL (61 kDa, 2), ReBALmat
(61 kDa, 3) and ReBALwid (61 kDa, lanes 4) were produced as pure enzymes in
biological triplicates and analyzed using a Coomassie stained 15% SDS tris-
glycine polyacrylamide gel. M: PageRuler Prestained Protein Ladder (Thermo
Scientific). B) Average thermal inactivation curves with 95% confidence
interval of all four purified BAL enzymes at an identical concentration of
5 μM after 10 min incubation in 50 mM KPi reaction buffer pH 8 containing
2.5 mM MgSO4 and 0.25 mM ThDP (for individual data sets see Figures S6–
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In order to further explore the differences in the molecular
structure of the binding site on the enzymatic properties, we
characterized the four BAL variants regarding their individual
substrate spectrum using 16 aromatic aldehydes (1a–p,
Scheme 2) for aromatic homo-coupling and aromatic-aliphatic
cross-coupling reactions with 2,2-dimethoxyacetaldehyde (3,
Scheme 1). Since many of these substrates are only poorly
soluble in aqueous buffers, we used 20% DMSO as co-solvent,
which had been previously reported for the PfBAL.[15] The
conversion of substrate and formation of product was deter-
mined by thin-layer chromatography (TLC, Figure S12) after
20 h incubation at 30 °C (Table 1). Compared to PfBAL, ReBAL
showed a similar but less broad substrate spectrum for the
homo-coupling reactions with considerably lower formation of
2h, 2 i, 2 l and 2p. This indicates that ReBAL does not accept
substrates with polar, aprotic para-substitutions as well as
pyridine compounds. As expected, matching the binding site of
ReBAL (ReBALmat) to the residues found in PfBAL restored an
almost identical substrate pattern while losing reactivity against
2d. In contrast, the simple widening of the binding site by the
introduction of alanine and glycine residues did not signifi-
cantly alter the substrate spectrum. When compared to the
wild-type ReBAL, the ReBALwid no longer accepts 2d but gains
some reactivity towards 2p.
However, the impact of the mutations was found to be
different for the cross-coupling reactions with substrate 3. While
ReBAL performed quite poorly in these reactions, only accepting
1h with >10% conversion, the introduction of the mutations
into the ReBAL binding site improved the ability to catalyze the
cross-coupling. Again, the substrate scope of the ReBALmat
showed a high similarity to PfBAL albeit with an overall lower
conversion. Like in the case of the homo-coupling reactions,
here the ReBALwid only showed a slightly altered reactivity
compared to the wild-type ReBAL with better acceptance of
substrate 1a, 1b, 1 j and 1o, although with loosing acceptance
of 1h and 1 l. These results clearly illustrate that the substrate
spectrum of the wild-type ReBAL can be aligned with the PfBAL
enzyme by replacing specific amino acids within the binding
site. Of note, similar as PfBAL, these ReBAL variants also showed
a clear (R)-selectivity for the formation of the homo- and cross-
coupling products of 1b. The stereoselectivity of the products
was confirmed by determining the enantiomeric excess of 2b
(Figure S13) as well as preparation and analysis of Mosher ester
derivatives[39] of the reaction product 4b with Mosher acid
chloride (Figures S14–S16) using the known stereoselectivity of
PfBAL with 4b as reference.[8]
In order to expand the range of hydrophobic substrates of
the BALs variants, we also wanted to investigate the effects of
possible co-solvents. To this end, we analyzed the change in
reactivity of the four BAL variants in ten different reaction
mixtures (Figure 4A). Since we found only minor differences for
the reaction in co-solvent-free buffer at either pH 7 or pH 8, we
chose pH 8 as the reference for the assessment of the effect of
co-solvent addition, since it was employed also in earlier studies
(for direct comparison of the activities of the different enzymes
with each other, see Figure 4B).[15,38,40] We investigated reaction
mixtures containing 40% choline-based deep eutectic solvents
(DES) because this type of solvents has been reported to enable
the conversion of hydrophobic substrates.[41] We found an
overall lower conversion for all four enzymes in the presence of
choline : glycerol (G-DES). Addition of 20% tert-butanol, 5%
tetrahydrofuran (THF), 5% 2-methyltetrahydrofuran (2-MTHF) or
5% acetonitrile led to similar or a decreased enzymatic activity,
and 20% dimethyl sulfoxide (DMSO) led to the already reported
increased performance of PfBAL.[15,38,42,43] Interestingly, ReBAL
was not significantly affected by this solvent and the effect of
20% DMSO on enzymatic performance appears to be selective
for the architecture of the binding site of PfBAL, as the activity
Table 1. Evaluation of BAL-catalyzed conversion of 1a–p into homo-coupling product 2 and aromatic-aliphatic cross-coupling products 4 with 3 (see
Scheme 1) by TLC analysis (see Figure S12) after 20 h.[a] The numbers indicate %-values of total conversion, determined via grayscale analysis of spot
intensities at 245 nm (Figure S11A). In some cases (*), the TLC method used could not clearly confirm product formation[b] or product formation could not be



















a 34 57 62 55 87 n.d. 5 20
b 60 68 66 64 87 6 20 16
c 41 17 22 16 87 n.d. n.d. n.d.
d *[b,c] *[b,c] n.d. n.d. *[b] *[b] *[b] *[b]
e *[b] *[b] *[b] *[b] 49 *[b] *[b] *[b]
f 35 17 22 18 94 *[b] *[b,c] *[b,c]
g 59 25 17 10 89 *[b,c] *[b] *[b,c]
h 89 4 71 11 *[b] 45 *[b] *[b]
i 84 3 19 5 33 n.d. 9 n.d.
j n.d. n.d. n.d. n.d. 9 n.d. 11 6
k 3 n.d. 3 1 36 n.d. n.d. n.d.
l 99 16 45 11 46 2 3 n.d.
m 56 52 53 38 81 n.d. n.d. n.d.
n n.d. n.d. n.d. n.d. n.d. n.d. n.d. n.d.
o 75 63 66 70 51 4 43 10
p 28 9 13 20 n.d. n.d. n.d. n.d.
[a] Reaction conditions: 5–10 mM aromatic aldehyde (1a–p) and 100 mM 3 in 50 mM KPi buffer (0.25 mM ThDP, 2.5 mM MgSO4, 20% DMSO, pH 8), 2 h at
30 °C; BAL final concentration: 5 μM; Reaction volume: 100 μL. [b] Possible overlay of homo-coupling, oxidation or autocatalytic product on the TLC. [c]
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of ReBALmat increased while ReBALwid remained unaffected. The
activity of PfBAL also increased with the addition of 20%
acetone, which had no significant effect on ReBAL but also
increased the activity of ReBALmat and ReBALwid. Surprisingly, the
presence of 20% isopropanol also significantly increased the
activity of ReBALmat and ReBALwid. These results suggest a better
interaction between the substrate and the less polar binding
site architecture of ReBALmat and ReBALwid in the presence of
these solvents. This is consistent with previously reported data
in which a modulation of catalytic properties for thiamine-
diphosphate-dependent enzymes was found due to a direct
interaction of small co-solvent molecules with the nonpolar
binding site.[42] In addition, the effects observed here may also
be related to an interdependent effect of binding site
architecture and surface hydrophobicity that affects enzyme
performance (for a detailed discussion, see Figure S17). The
finding of an increased performance with isopropanol was very
promising for the application of the enzymes in flow reactors
since the use of DMSO as a co-solvent can lead to problems
during the workup procedure,[44] whereas isopropanol can be
easily removed under reduced pressure.
To evaluate whether the newly identified ReBAL is suitable
for the application in a continuous flow reactor, we chose the
homo-coupling of 1b as a model reaction and the SpyCatcher/
SpyTag system[45] for site-selective enzyme immobilization in a
packed-bed reactor setup. This strategy allows an efficient and
covalent immobilization under mild reaction conditions onto
beads,[46] which has already been exploited, for example, to
generate meso diols from ketones using alcohol
dehydrogenases.[47] Prolonged reaction times are desirable in a
packed-bed reactor, requiring stable enzymes. Here we used
the ReBALwid variant, since higher thermostability is often also
associated with greater overall robustness.[48] To enable site-
selective, covalent immobilization for the flow biocatalysis, the
SpyTag (ST) peptide was genetically fused to the C-terminus of
the enzyme to generate a ReBALwid-ST (for the corresponding
primer sequences see Table S3), which can then be coupled to
a solid support bearing the complementary SpyCatcher (SC)
unit.[47]
After heterologous expression in E. coli and purification, we
initially confirmed that the activity of the ReBALwid-ST is
comparable to the other untagged ReBAL variants (Figure 5A).
The ReBALwid-ST was then immobilized onto microbeads
bearing the SC protein[49] and the resulting ReBALwid-ST@SC-
Beads were loaded into custom-made PTFE microreactors
(Figure S18) with a reactor volume of 200 μL. We selected 20%
isopropanol as the co-solvent since it enhanced the perform-
ance of the enzyme (Figure 4A). Two packed-bed reactors were
perfused in parallel with 30 mM 1b in 80% cofactor-containing
KPi buffer:20% isopropanol at a constant flow rate of
1 μL ·min  1 (Figure 5B). The reactor outflows were sampled at
defined time intervals and analyzed by reverse-phase HPLC.
Under these reaction conditions, in total 20 mL of 1.3�0.3 mM
2b were steadily generated over seven days (Figure 5C) with a
space-time yield (STY) of 9.3 mmol · L-1 ·d  1. In comparison to
other studies using PfBAL in a continuous reaction system[16–19]
the system developed here has the clear advantages of
enabling long process times and employing simple process
conditions such as homogeneous reaction media, easily scalable
reactor design[50] e.g. via numbering-up.[51]
Conclusion
In conclusion, our work emphasizes that modeling-assisted
rational design of ReBAL enzymes in combination with robust
immobilization strategies is a powerful approach to create
novel biocatalytic processes for continuous production of
valued-added molecules. Specifically, we herein demonstrated
the immobilization of a thermostable benzaldehyde lyase in a
continuous packed-bed microreactor for the production of α-
hydroxy ketones with constant activity over days. In this
context, we screened three previously uncharacterized ThDP-
dependent enzymes for aromatic ligase activity and identified
Figure 4. Conversion of 1b into 2b by PfBAL (gray bars), ReBAL (red bars), ReBALmat (blue bars) and ReBALwid (green bars) after 1 h. A) Activities in the presence
of different co-solvents (v/v) relative to the formation in potassium phosphate (KPi) buffer pH 8. PfBAL (20 nM) and ReBAL enzymes (200 nM) with 0.25 mM
ThDP were incubated in mixtures of 50 mM KPi buffer pH 8 and 2.5 mM MgSO4 with different co-solvents and 30 mM 1b at 30 °C. Note that the activities are
given for each BAL variant relative to the activity of the same variant at pH 8 without co-solvent to allow direct comparison of the effect of co-solvents on the
individual BAL variants. To allow a direct comparison of the activities of the different enzymes with each other, the turnover number for all four BAL variants
in potassium phosphate (KPi) buffer pH 8 are shown in B). Analyses were carried out at least in technical and biological duplicates. Solvents: KPi buffer pH 8,
KPi buffer pH 7, 40% choline : glycerol DES (G-DES), 20% tert-butanol, 5% tetrahydrofuran (THF), 5% 2-methyltetrahydrofuran (2-MTHF), 5% acetonitrile, 20%
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ReBAL as a novel benzaldehyde lyase. After modeling the
protein structure of ReBAL, two rationally designed variants
with altered binding sites were generated. Compering these
three benzaldehyde lyase variants with the literature described
PfBAL, we showed that ReBAL is more thermostable while being
less active and having a narrower substrate spectrum. However,
the ReBALmat variant whose binding site was designed to match
with PfBAL recovered the substrate scope. The most thermo-
stable ReBALwid variant was then immobilized for the continuous
flow biocatalysis where it showed a stable conversion over
seven days. Our experiments expand the availability of enzymes
for the continuous production of α-hydroxy ketones and
therefore can enhance the usability of this important enzyme
class in biotechnological production processes. Since thermo-
stable enzymes in general tolerate more mutations,[52] we
envision that the more stable ReBAL backbone identified in this
work can be further modified using protein engineering to
create completely novel reactivities and produce important
enantiopure building blocks for the synthesis of APIs.
Experimental Section
Experimental details can be found in the Supporting Information.
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A novel benzaldehyde lyase for the
production of chiral α-hydroxy
ketones was identified by a machine
learning model and two variants with
altered substrate scopes were
created by rational design. All three
variants exhibit significantly higher
thermostability compared to the only
previously described benzaldehyde
lyase. When immobilized in a
packed-bed reactor, the most ther-
mostable variant showed stable
substrate turnover over days.
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